Lei Yi, Yang Jie, Li Yongqiang, Yu Xudong, Deng Sheng, Xue Chaohui, Zheng Wei, Shang Jianwei, Xue Yahui
Department of Andrology, The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, Shaanxi.
Beijing Fengtai Maternal & Child Health Hospital.
Medicine (Baltimore). 2019 Jun;98(24):e15975. doi: 10.1097/MD.0000000000015975.
Epididymitis is a common disease in nonspecific infections of the male reproductive system according to the clinical incidence of acute epididymitis and chronic epididymitis. Many clinical trials have proven that Chinese medicine has a significant effect in the treatment of epididymitis. In this systematic review, we aim to evaluate the effectiveness and safety of traditional Chinese medicine (TCM) for epididymitis.
We will search for PubMed, Cochrane Library, AMED, Embase, WorldSciNet, Nature, Science online, China Journal Full-text Database (CNKI), China Biomedical Literature CD-ROM Database (CBM), and related randomized controlled trials included in the China Resources Database. The time is limited from the construction of the library to November 2018. We will use the criteria provided by Cochrane 5.1.0 for quality assessment and risk assessment of the included studies, and use the Revman 5.3 and Stata13.0 software for meta-analysis of the effectiveness, recurrence rate, and symptom scores of epididymitis.
This systematic review will evaluate the efficacy and safety of TCM for treating epididymitis. Because all of the data used in this systematic review and meta-analysis has been published, this review does not require ethical approval. Furthermore, all data will be analyzed anonymously during the review process.Registration number: PROSPERO CRD42019130569.
根据急性附睾炎和慢性附睾炎的临床发病率,附睾炎是男性生殖系统非特异性感染中的常见疾病。许多临床试验已证明中药在附睾炎治疗中具有显著效果。在本系统评价中,我们旨在评估中药治疗附睾炎的有效性和安全性。
我们将检索PubMed、Cochrane图书馆、AMED、Embase、WorldSciNet、《自然》《科学》在线、中国期刊全文数据库(CNKI)、中国生物医学文献光盘数据库(CBM)以及华润数据库中纳入的相关随机对照试验。时间范围为从建库至2018年11月。我们将使用Cochrane 5.1.0提供的标准对纳入研究进行质量评估和风险评估,并使用Revman 5.3和Stata13.0软件对附睾炎的有效性、复发率和症状评分进行荟萃分析。
本系统评价将评估中药治疗附睾炎的疗效和安全性。由于本系统评价和荟萃分析中使用的所有数据均已发表,因此本评价无需伦理批准。此外,在评价过程中所有数据将进行匿名分析。注册号:PROSPERO CRD42019130569。